Overview
Current NAV
15.4053
As on 30-Dec-2025
Fund Size
378.531 Cr
Managed by Sanjeev Sharma
Expense Ratio
0.83%
Latest reported
Exit Load Rules
2
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 17-Jul-2023. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.75 | — | — | — |
| 1W | -1.88 | — | — | — |
| 1M | -3.02 | — | — | — |
| 3M | -0.78 | — | 1.47 | — |
| 6M | -4.50 | — | 0.20 | — |
| 1Y | -3.12 | — | -2.14 | — |
| 3Y | — | — | 22.11 | — |
| 5Y | — | — | 14.61 | — |
| 10Y | — | — | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Cipla Ltd.
EQ
Healthcare
9.77
SMS Pharmaceuticals Ltd.
EQ
Healthcare
9.66
Sequent Scientific Ltd.
EQ
Healthcare
8.72
Aster DM Healthcare Ltd.
EQ
Healthcare
7.85
Zydus Wellness Ltd.
EQ
Consumer Staples
7.30
Aurobindo Pharma Ltd.
EQ
Healthcare
7.04
Pfizer Ltd.
EQ
Healthcare
6.30
Alivus Life Sciences Ltd
EQ
Healthcare
5.85
Adani Enterprises Ltd.
EQ
Services
5.72
Anthem Biosciences Ltd.
EQ
Healthcare
5.59
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
4.80
Divi's Laboratories Ltd.
EQ
Healthcare
3.49
Analysis Highlights
PROS
Lower expense ratio: 0.83%
CONS
1Y annualised returns lower than category average by 0.98%
Exit Load
- Exit load of 1%, if redeemed within 15 days.2023-08-11
- No description2023-06-27